T1DX-QI has continued to grow and now includes 63 T1D centers and 25 T2D centers. Of these, 49 T1D centers have completed data mapping (with 5 in progress), and 6 T2D centers have completed data mapping (with 5 in progress).
The T1DX-QI database now includes data from 90,000+ people with T1D and 60,000+ people with T2D across 23 U.S. states. We have surpassed 100 publications in top journals and delivered over 250 presentations at international conferences.
This year was no small feat. T1DX-QI is well-positioned to continue driving measurable and sustainable improvements in diabetes outcomes. We look forward to an even stronger 2026!
T1DX-QI Learning Session 2025
Thank you to everyone who attended and contributed to the 2025 T1DX-QI Learning Session in Atlanta, GA! We greatly appreciate your commitment to the collaborative and hope you found the sessions valuable.
We would also like to extend our gratitude to our local hosts, Children’s Healthcare of Atlanta and Grady Memorial Hospital, and to their wonderful teams who made us feel at home.
All presentations, posters, abstracts, and recordings will be available on the member website. Please remember to share your Learning Session feedback using this link.
Congratulations to the T1DX-QI 2025 Award Recipients!
Our recent Learning Session featured an outstanding 4T Panel, and we’re excited to share more resources with you. Start by exploring this article from the Stanford University team and review the additional links below for more insights.
Thank you to our T1DX-QI Learning Session 2025 Sponsors and Supporting Companies
T1DX Welcomes Four Medical Director Advisors
Agreements are currently under review or have been completed with four advisors who bring varying levels of focus on QI-related work and other T1D Exchange research opportunities. Together, they offer collective expertise across a wide range of areas, strengthening our capacity to execute high-quality work and enhancing our competitiveness in pursuing new grant applications and meaningful industry-sponsored projects.
From left to right: Nestoras Mathioudakis, MD, MHS (Johns Hopkins University), Jenise Wong, MD, PhD (UCSF), David Walton, MBA (T1D Exchange), Jennifer Sherr, MD, PhD (Yale University), and Viral Shah, MD (Indiana University)
ISPAD 2025 in Montreal
We hope that everyone who presented at and attended ISPAD last month had a wonderful time!
Elizabeth Mann, MD (UW Health) presenting at ISPAD 2025.